Amal Abd El-hafez
Overview
Explore the profile of Amal Abd El-hafez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fawzy M, Abd El-hafez A, El-Ashwah S, Abouzeid T, Waheeb M, Saif M, et al.
Asian Pac J Cancer Prev
. 2021 Jul;
22(7):2143-2152.
PMID: 34319037
Introduction: Recently, isolated myeloperoxidase expression (isoMPO) has been documented in B-acute lymphoblastic leukemia (B-ALL) and several contradictory studies addressed its clinical significance in pediatric patients. Aim: In this study, isoMPO...
2.
Abd El-hafez A, Hany H
Asian Pac J Cancer Prev
. 2020 Aug;
21(8):2403-2413.
PMID: 32856872
Objectives: This tissue microarray (TMA) immunohistochemical (IHC) study elucidates the role of Wilms' tumor 1 protein (WT1) in diagnosis and prognostication of astrocytic tumors. Methods: IHC was applied to 75...
3.
Shawky A, Abd El-hafez A, El-Tantawy D, Hamdy R
Asian Pac J Cancer Prev
. 2014 Jun;
15(10):4275-9.
PMID: 24935384
Background: The aim of this work is to assess the frequency of BRCA1 protein immunohistochemical (IHC) expression in epithelial ovarian cancer (EOC) and to evaluate the association of BRCA1 expression...
4.
Abd El-hafez A, Shawky Mohamed A, Elesawy B
Asian Pac J Cancer Prev
. 2013 Apr;
14(2):1037-41.
PMID: 23621182
Background: Prognostication of breast cancer using clinico-pathologic variables, although useful, remains imperfect. Recent research has focused on finding new markers of prognosis using gene expression profiling. Panels of proteins assessed...
5.
Abd El-hafez A, El Aaty Shawky A, Hasan B
Cancer Biomark
. 2013 Apr;
12(4):149-54.
PMID: 23568005
Background: Strong evidence implicates cyclin D1 in human breast cancer. Nevertheless, the prognostic value of cyclin D1 overexpression in breast cancer is still controversial. This work aims to assess the...